Renoprotective Effects of DPP-4 Inhibitors
Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a u...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2021-02-01
|
| Collection: | Antioxidants |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/2076-3921/10/2/246 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|